Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Phase 3 Study of KW-6002 in Parkinson's Disease
jRCT2080220820Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Istradefylline in Parkinson's disease (PD) (3 arms), sponsored by Kyowa Kirin.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080220820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220820.